Targets move toward the 25-meter line during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

Rubber training pistols, magazines, and dummy cartridges sit ready for use during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

An Alternate Pistol Qualification Course Scorecard sits ready for use during the U.S. Army Medical Materiel Development Activity’s pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

Soldiers assigned to the U.S. Army Medical Materiel Development Activity listen during pistol functions training as part of a pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

Soldiers assigned to the U.S. Army Medical Materiel Development Activity listen during pistol functions training as part of a pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

Soldiers assigned to the U.S. Army Medical Materiel Development Activity listen during pistol functions training as part of a pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

A 25 Meter E Silhouette target sits ready for use during the U.S. Army Medical Materiel Development Activity’s pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Lt. Col. Dana Bal practices sight alignment with rubber pistols during a pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Bal is a pharmacist and assistant program manager with USAMMDA’s Warfighter Brain Health Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

U.S. Army Capt. Brian Robinette aims toward a practice target during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Robinette is an assistant program manager with USAMMDA. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

Soldiers assigned to the U.S. Army Medical Materiel Development Activity practice sight alignment with rubber pistols during a pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Lt. Col. Sheila Johnson aims toward a practice target during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

Soldiers assigned to the U.S. Army Medical Materiel Development Activity practice sight during a pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

A practice target sits down range during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

U.S. Army Lt. Col. Sheila Johnson, left, and Lt. Col. Dana Bal affix targets to a moving carriage during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office and Bal is an assistant product manager with the Warfighter Brain Health PMO. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

Soldiers prepare to fire at practice targets during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

An expended 9 mm pistol cartridge cools after firing during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Col. Andy Nuce, left, and Kenner Samuels inspect a target during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Nuce is the commander and Kenner is the operations chief, both with USAMMDA. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

U.S. Army Lt. Col. Sheila Johnson inspects her target during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Soldiers listen to safety instructions during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

U.S. Army Lt. Col. Sheila Johnson loads a 9 mm pistol magazine during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Lt. Col. Charles Bane loads a 9 mm pistol magazine during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Bane is the director of USAMMDA’s Force Health Protection Division. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

U.S. Army Lt. Col. Sheila Johnson loads a 9 mm pistol magazine during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Lt. Col. Sara Harmon, left, and Col. Andy Nuce fire from the prone position during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Harmon the deputy commander and Nuce is the commander, both with USAMMDA. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by Cameron E. Parks/Released)

U.S. Army Lt. Col. Sheila Johnson inspects her target during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Lt. Col. Sheila Johnson, left, and Lt. Col. Dana Bal load 9 mm pistol magazines during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office and Bal is an assistant product manager with the Warfighter Brain Health PMO. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

A 25-meter E Silhouette returns to the firing line during the U.S. Army Medical Materiel Development Activity’s pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25-meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Lt. Col. Sheila Johnson fires from the prone position during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25-meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

U.S. Army Lt. Col. Sheila Johnson listens to safety instructions during a U.S. Army Medical Materiel Development Activity pistol familiarization and qualification range, Frederick, Md., Sept. 8, 2023. Johnson is product manager with the Warfighter Protection and Acute Care Project Management Office. As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters. USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities. (U.S. Army Photo by T. T. Parish/Released)

All eyes were on target during the U.S. Army Medical Materiel Development Activity’s annual pistol qualification course last week in Frederick, Maryland. The event, which gives USAMMDA’s Soldier Scientists a chance to build on their soldiering fundamentals, took place Sept. 8, 2023.

As part of the range, USAMMDA’s active-duty officers fired 40 9 mm pistol rounds apiece during four courses of fire: standing, kneeling, crouching, and prone from 25 meters.

USAMMDA, the U.S. Army’s premier developer of new drugs, vaccines, devices, and medical support equipment, routinely partners with both U.S. Department of Defense units and non-DOD organizations to provide Warfighters high-quality medical capabilities.